| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
29,581,926 | 29,061,044 | 31,565,763 | 28,449,855 | 29,482,106 |
| Cost of Revenue
|
-25,056,105 | -24,619,111 | -26,858,737 | -24,111,218 | -25,077,369 |
|
Gross Profit
|
4,525,821 | 4,441,932 | 4,707,026 | 4,338,637 | 4,404,737 |
|
Operating Income/Expenses
|
-2,985,642 | -2,947,574 | -3,022,708 | -2,823,637 | -2,710,499 |
|
Total Operating Profit/Loss
|
1,540,179 | 1,494,358 | 1,684,318 | 1,515,000 | 1,694,238 |
| Total Net Finance Income/Expense
|
26,172 | 20,131 | 23,698 | 22,456 | 13,800 |
| Net Investment Income
|
82,569 | 81,484 | 87,838 | 41,247 | 341,636 |
| Irregular Income/Expenses
|
4,799 | 9,628 | 0 | -571 | 0 |
|
Other Income/Expense, Non-Operating
|
35,632 | 35,475 | 47,302 | 35,649 | 48,328 |
|
Non-Operating Income/Expenses, Total
|
149,172 | 146,718 | 158,838 | 98,781 | 403,764 |
|
Pretax Income
|
1,689,353 | 1,641,077 | 1,843,158 | 1,613,781 | 2,098,004 |
| Provision for Income Tax
|
-552,611 | -533,440 | -611,716 | -539,005 | -668,472 |
|
Net Income from Continuing Operations
|
1,136,742 | 1,107,637 | 1,231,442 | 1,074,776 | 1,429,532 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,136,743 | 1,107,637 | 1,231,441 | 1,074,775 | 1,429,531 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 0 | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
1,136,743 | 1,107,637 | 1,231,441 | 1,074,775 | 1,429,531 |
|
Net Income Available to Common Stockholders
|
1,136,743 | 1,107,637 | 1,231,441 | 1,074,775 | 1,429,531 |
|
Diluted Net Income Available to Common Stockholders
|
1,136,743 | 1,107,637 | 1,231,441 | 1,074,775 | 1,429,531 |
| Basic EPS
|
290.14 | 281.86 | 310.89 | 264.94 | 340.14 |
| Diluted EPS
|
289.94 | 281.66 | 310.68 | 264.69 | 339.83 |
|
Basic Weighted Average Shares Outstanding
|
3,919.60 | 3,929.74 | 3,961.03 | 4,056.67 | 4,202.77 |
|
Diluted Weighted Average Shares Outstanding
|
3,922.39 | 3,932.53 | 3,963.70 | 4,060.51 | 4,206.61 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,663,181 | 1,620,946 | 1,819,460 | 1,591,325 | 2,084,204 |
|
EBITDA
|
1,827,936 | 1,827,936 | 2,026,613 | 1,746,198 | 2,165,335 |
|
Normalized EBITDA
|
1,799,188 | 1,799,188 | 1,995,555 | 1,750,644 | 1,868,149 |
|
Normalized Income
|
1,665,432 | 1,612,328 | 1,812,100 | 1,618,224 | 1,800,817 |
|
Total Unusual Items
|
-4,799 | -28,748 | -31,058 | 4,446 | -297,186 |
|
Total Unusual Items Excluding Goodwill
|
-4,799 | -28,748 | -31,058 | 4,446 | -297,186 |
|
Tax Effect of Unusual Items
|
-1,569.82 | -9,343.10 | -10,311.26 | 1,484.96 | -94,690.29 |
3/31/2023 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade